BACE2 as a new diabetes target: a patent review (2010 - 2012)
Expert Opinion on Therapeutic Patents (2013) - Comments
pubmed: 23506624  doi: 10.1517/13543776.2013.780032  issn: 1744-7674  issn: 1354-3776 

Christopher Southan